All Stories

Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.

Mar 17, 2025 - 10:13
 0
Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.
Read More

Tags:

Previous Article

$4,750 Rentals in Los Angeles

Next Article

Construction of KF‐Rich Solid Electrolyte Interfaces Based on the Electrodeposit...

Related Posts

FDA updates Boston Scientific's Accolade pacemaker recall, reporting 832 injuries

FDA updates Boston Scientific's Accolade pacemaker reca...

Feb 25, 2025  0

Tasso rolls out new at-home dried blood spot sample collectors for remote clinical trials

Tasso rolls out new at-home dried blood spot sample col...

Feb 10, 2025  0

Cell death biotech Kojin winds down, citing 4 funding challenges

Cell death biotech Kojin winds down, citing 4 funding c...

Feb 14, 2025  0